Xenikos announces first patient receives T-Guard(R) for steroid-refractory acute GVHD in pivotal U.S.-based Phase 3 trial - Yahoo Finance

Xenikos announces first patient receives T-Guard(R) for steroid-refractory acute GVHD in pivotal U.S.-based Phase 3 trial  Yahoo Finance